GlassScriptPhysician profile
John W Shuck
NPI 1689641086
$3,098.28
in general payments reported to CMS, 2019-2025
13 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $109 · 2021: $1,845 · 2022: $120 · 2024: $270 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $1,684.33 | 2021 | |
| Mentor Worldwide LLC | $544.24 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $181.39 | 2025 | |
| Medtronic, INC. | $127.73 | 2021 | |
| Boston Scientific Corporation | $119.70 | 2019-2022 | |
| Allergan, INC. | $95.75 | 2022 | |
| Medtronic Vascular, INC. | $78.41 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.21 | 2019-2021 | |
| Pfizer INC. | $62.88 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $59.28 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $36.76 | 2019 | |
| Amarin Pharma, INC. | $20.13 | 2019 | |
| Amgen INC. | $13.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Shuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.